More and more cases continue to be filed involving Xarelto®, the Janssen pharmaceutical blood thinner that has been found to result in serious side effects and in some cases even death. Xarelto® first came to market in 2011 as a competitor to existing blood-thinning drugs such as warfarin. The drug